Divalproex Sodium
Overview
Divalproex Sodium is a medication primarily used to treat seizure disorders, bipolar disorder, and to prevent migraine headaches. It is a stable co-ordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship.
API suppliers (12)
Suppliers of Divalproex Sodium evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 11 of 12 suppliers.
6 of 12 hold a GMP certificate on record in the EU or UK registers
- Hetero Drugs LimitedIndia1 active DMF GMP on record
- PCASFrance1 active DMF GMP on record
- Wockhardt UsaUnited Kingdom1 active DMF
- SCI PHARMTECH INCTaiwan1 active DMF
- Suven Life Sciences LimitedIndia1 active DMF
- ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF GMP on record
- KATWIJK CHEMIE BVNetherlands1 active DMF GMP on record
- CILAG AGSwitzerland GMP on record
- PROCOS SPAItaly GMP on record
- CHENG FONG CHEMICAL CO LTDTaiwan
- Genesen Labs LtdIndia
- SELOC FRNCE
Therapeutic areas
Do you supply Divalproex Sodium? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.